|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.91 USD | -0.88% |
|
+1.15% | -15.89% |
| 06-24 | AlphaValue/Baader Europe Reduces EPS Estimates for Genmab on Merger Financing Costs | MT |
| 06-23 | Genmab: Financing weighs now, pipeline pays later |  |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
 | 55.35B | A | |||||||
| 51.92B | AAA | |||||||
| 22.76B | - | - | - | - | ||||
| 22.64B | - | A | - | - | ||||
| 17.36B | AAA | |||||||
| 13.96B | AA | |||||||
| 13.38B | BB | |||||||
| 12.27B | - | AA | - | - | ||||
| 11.85B | - | B | - | - | ||||
| 11.17B | - | BB | - | - | ||||
| 11.01B | - | - | - | - | ||||
| 10.97B | - | AA | - | - | ||||
| 10.04B | B | |||||||
| 9.76B | - | CCC | - | - | ||||
| 8.16B | - | CCC | - | - | ||||
| 8.08B | - | |||||||
| 7.75B | - | BBB | - | - | ||||
| 7.7B | - | BB | - | - | - | |||
| 7.14B | B | |||||||
| Average | 16.49B | BBB | |||||||
| Weighted average by Cap. | BBB |
- Stock Market
- Stocks
- GMAB Stock
- GMAB Stock
- Sector Genmab A/S
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
